ALLO
Allogene Therapeutics Inc
1.40$
-2.1%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -252,409.1% | – | -254,086.4% | – | – | – | – | – | – | – | – | -689.6% | -2,202.5% | |
| 16,236.4% | – | 16,159.1% | – | – | – | – | – | – | – | – | 57.0% | 251.5% | |
| 69,790.9% | – | 54,200.0% | – | – | – | – | – | – | – | – | 268.1% | 808.0% | |
| -67,677.3% | – | -20,186.4% | – | – | – | – | – | – | – | – | -12.1% | 376.3% | |
| 54.5% | – | 36.4% | – | – | – | – | – | – | – | – | 3.2% | 8.7% | |
| -155,759.1% | – | 100,604.5% | – | – | – | – | – | – | – | – | -3,180.2% | -2,836.2% | |
| – | – | 3,890.9% | – | – | – | – | – | – | – | – | 9.7% | – | |
| 19,477.3% | – | 7,500.0% | – | – | – | – | – | – | – | – | 4,049.0% | 4,743.3% | |
| -388,690.9% | – | -145,981.8% | – | – | – | – | – | – | – | – | 179.2% | -295.4% | |
| -252,463.6% | – | -254,122.7% | – | – | – | – | – | – | – | – | -692.8% | -2,211.2% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.